Sun Sep 15 14:20:56 UTC 2024: ## Institutional Investors Show Interest in Encompass Health Co. (EHC)

**New York, NY** – Encompass Health Co. (NYSE:EHC) has seen a surge in interest from institutional investors, with several funds buying or increasing their holdings in the post-acute healthcare provider during recent quarters. Notably, Bokf Na purchased a new stake in Encompass Health, acquiring 16,189 shares valued at approximately $1,389,000.

Other notable moves include Commonwealth Equity Services LLC increasing its holdings by 1.3%, Legacy Wealth Asset Management LLC lifting its stake by 1.5%, and Smith Group Asset Management LLC boosting its position by 1.2%.

This institutional activity comes alongside positive analyst sentiment. Royal Bank of Canada, Leerink Partners, Barclays, and UBS Group have all raised their price objectives on Encompass Health shares, with several analysts issuing “buy” or “strong-buy” ratings. The average rating for the stock currently sits at “Buy” with a consensus target price of $100.38.

Encompass Health’s recent financial performance further fuels investor optimism. The company exceeded analysts’ expectations in the second quarter, reporting earnings per share of $1.11, surpassing the estimated $1.01. Revenue for the quarter also reached $1.30 billion, aligning with analyst projections.

However, it’s worth noting that Encompass Health’s CFO, Douglas E. Coltharp, sold 12,260 shares of the company’s stock in a transaction on August 13th. The transaction, disclosed in an SEC filing, raises some questions about his confidence in the company’s future prospects.

Overall, the recent influx of institutional investment, coupled with positive analyst sentiment and strong financial performance, points towards a positive outlook for Encompass Health. However, the CFO’s recent stock sale warrants close monitoring as it could signal potential concerns about the company’s trajectory.

Read More